Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Median time to pain improvemen...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Bibliographic Details
Main Authors: de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P
Format: Conference item
Published: Wiley 2018
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
    by: de Vlam, K, et al.
    Published: (2021)
  • Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
    by: Ogdie, A, et al.
    Published: (2018)
  • Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
    by: Taylor, P, et al.
    Published: (2019)
  • Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
    by: de Vlam, K, et al.
    Published: (2022)
  • Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
    by: Taylor, PC, et al.
    Published: (2020)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs